English | 繁體

Search in the results

UM

Browse/Search Results:  1-8 of 8 Help

Selected(0)Clear Items/Page:    Sort:
Digital Microfluidics with an On-Chip Drug Dispenser for Single or Combinational Drug Screening Book chapter
出自: Methods in Molecular Biology:Humana Press Inc., 2023, 页码:25-39
Authors:  Li,Caiwei;  Zhai,Jiao;  Jia,Yanwei
Favorite | TC[Scopus]:0 | Submit date：2023/08/03
Cancer Drug Screening  Cisplatin  Digital Microfluidics  Drug Dispenser  Epirubicin  Mcf-10a Cell  Mda-mb-231 Cell  
Pharmacological inhibition of KDM5A for cancer treatment Journal article
Yang, Guan Jun, Wu, Jia, Miao, Liang, Zhu, Ming Hui, Zhou, Qian Jin, Lu, Xin Jiang, Lu, Jian Fei, Leung, Chung Hang, Ma, Dik Lung, Chen, Jiong. Pharmacological inhibition of KDM5A for cancer treatment[J]. European Journal of Medicinal Chemistry, 2021, 226, 113855.
Authors:  Yang, Guan Jun;  Wu, Jia;  Miao, Liang;  Zhu, Ming Hui;  Zhou, Qian Jin; et al.
Favorite | TC[WOS]:26 TC[Scopus]:28  IF:6.0/6.1 | Submit date：2021/12/08
Cancer Therapy  Drug Resistance  Histone Methylation  Lysine-specific Demethylase 5a  Screening Methods  
Patient-Derived Organoids Can Guide Personalized-Therapies for Patients with Advanced Breast Cancer Journal article
Ping Chen, Xu Zhang, Renbo Ding, Linglin Yang, Xueying Lyu, Jianming Zeng, Josh Haipeng Lei, Lijian Wang, Jiong Bi, Nan Shao, Ditian Shu, Bin Wu, Jingbo Wu, Zhihui Yang, Haiyan Wang, Biqiong Wang, Kang Xiong, Yun Lu, Shaozhi Fu, Tak Kan Choi, Ng Wai Lon, Aiping Zhang, Dongyang Tang, Yingyao Quan, Ya Meng, Kai Miao, Heng Sun, Ming Zhao, Jiaolin Bao, Lei Zhang, Xiaoling Xu, Yanxia Shi, Ying Lin, Chuxia Deng. Patient-Derived Organoids Can Guide Personalized-Therapies for Patients with Advanced Breast Cancer[J]. Advanced Science, 2021, 8(22), 2101176.
Authors:  Ping Chen;  Xu Zhang;  Renbo Ding;  Linglin Yang;  Xueying Lyu; et al.
Favorite | TC[WOS]:88 TC[Scopus]:89  IF:14.3/16.3 | Submit date：2021/11/30
Advanced Breast Cancer  Drug Screening  Patient-derived Organoids  Personalized Therapy  
Expansion of Rare Cancer Cells into Tumoroids for Therapeutic Regimen and Cancer Therapy Journal article
Enkhbat, Myagmartsend, Liu, Yung Chiang, Kim, Jua, Xu, Yanshan, Yin, Zongyi, Liu, Tzu Ming, Deng, Chu Xia, Zou, Chang, Xie, Xi, Li, Xiaowu, Wang, Peng Yuan. Expansion of Rare Cancer Cells into Tumoroids for Therapeutic Regimen and Cancer Therapy[J]. Advanced Therapeutics, 2021, 4(7), 2100017.
Authors:  Enkhbat, Myagmartsend;  Liu, Yung Chiang;  Kim, Jua;  Xu, Yanshan;  Yin, Zongyi; et al.
Adobe PDF | Favorite | TC[WOS]:5 TC[Scopus]:4  IF:3.7/4.7 | Submit date：2021/12/08
Assembloid  Cancer Stem Cell  Circulating Tumor Cell  Drug Screening  Microenvironment  
Ubiquitination Regulators Discovered by Virtual Screening for the Treatment of Cancer Review article
2021
Authors:  Song, Ying Qi;  Wu, Chun;  Wu, Ke Jia;  Han, Quan Bin;  Miao, Xiang Min; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:4.6/5.2 | Submit date：2021/12/07
Ubiquitination Regulator  Virtual Screening  Drug Discovery  Cancer  Treatment  
A Three-Way Combinatorial CRISPR Screen for Analyzing Interactions among Druggable Targets Journal article
Zhou,Peng, Chan,Becky K.C., Wan,Yuk Kei, Yuen,Chaya T.L., Choi,Gigi C.G., Li,Xinran, Tong,Cindy S.W., Zhong,Sophia S.W., Sun,Jieran, Bao,Yufan, Mak,Silvia Y.L., Chow,Maggie Z.Y., Khaw,Jien Vei, Leung,Suet Yi, Zheng,Zongli, Cheung,Lydia W.T., Tan,Kaeling, Wong,Koon Ho, Chan,H. Y.Edwin, Wong,Alan S.L.. A Three-Way Combinatorial CRISPR Screen for Analyzing Interactions among Druggable Targets[J]. Cell Reports, 2020, 32(6), 108020.
Authors:  Zhou,Peng;  Chan,Becky K.C.;  Wan,Yuk Kei;  Yuen,Chaya T.L.;  Choi,Gigi C.G.; et al.
Favorite | TC[WOS]:26 TC[Scopus]:27  IF:7.5/8.5 | Submit date：2021/03/04
Cancer  Combigem  Combination Therapy  Combinatorial Genetics  Crispr  Drug Interaction  Genetic Interaction  High-throughput Screening  Neurodegeneration  Parkinson's Disease  
Genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients Journal article
Chen,Jing Hua, Chu,Xiang Peng, Zhang,Jia Tao, Nie,Qiang, Tang,Wen Fang, Su,Jian, Yan,Hong Hong, Zheng,Hong Ping, Chen,Ze Xin, Chen,Xin, Song,Meng Meng, Yi,Xin, Li,Pan Song, Guan,Yan Fang, Li,Gang, Deng,Chu Xia, Rosell,Rafael, Wu,Yi Long, Zhong,Wen Zhao. Genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients[J]. Thoracic Cancer, 2020, 11(8), 2279-2290.
Authors:  Chen,Jing Hua;  Chu,Xiang Peng;  Zhang,Jia Tao;  Nie,Qiang;  Tang,Wen Fang; et al.
Favorite | TC[WOS]:46 TC[Scopus]:47  IF:2.3/2.8 | Submit date：2021/03/02
Consistency Analysis  Drug Screening  Non-small Cell Lung Cancer  Patient-derived Organoid  Whole Exome Sequencing  
Recent advances in drug repositioning for the discovery of new anticancer drugs Review article
2014
Authors:  Joong Sup Shim;  Jun O. Liu
Favorite | TC[WOS]:293 TC[Scopus]:327  IF:8.2/8.3 | Submit date：2019/01/24
Drug Repositioning  Drug Discovery  Cancer  Angiogenesis  Drug Screening  Drug Library